Anthony Letai, Director of the National Cancer Institute, shared on X:
“I am hopeful that immunotherapy will help speed progress against pediatric brain tumors.
An NCI -supported phase 1 trial of a new multi-antigen T-cell therapy shows it is safe and, for some children, can lead to years of disease-free survival.”
Title: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial
Authors: Stephanie Gomez, Rachel A. DiCioccio, Ashley E. Geiger, Melanie L. Grant, Emily Reynolds, Anushree Datar, Chase D. McCann, Jay Tanna, Divyesh Kukadiya, Fahmida Hoq, Anqing Zhang, Patrick J. Hanley, Jennifer L. Webb, Lindsay B. Kilburn, Brian R. Rood, Adriana Fonseca, Holly J. Meany, L. Gilbert Vézina, Roger J. Packer, Conrad Russell Y. Cruz, Catherine M. Bollard, Eugene I. Hwang
Other articles about central nervous system tumors and T-cell therapy on OncoDaily.